Alerus Investment Advisors’s Pacira BioSciences PCRX Stock Holding History

Alerus Investment Advisors’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-292	Closed	-$22K	–	289
2015 Q4	$22K	Sell	292 -290	-50%	-$16.4K	﹤0.01%	155
2015 Q3	$24K	Hold	582	–	–	﹤0.01%	135
2015 Q2	$41K	Hold	582	–	–	0.01%	131
2015 Q1	$52K	Hold	582	–	–	0.01%	131
2014 Q4	$52K	Sell	582 -875	-60%	-$82.8K	0.01%	135
2014 Q3	$131K	Hold	1,457	–	–	0.02%	124
2014 Q2	$134K	Hold	1,457	–	–	0.02%	129
2014 Q1	$108K	Hold	1,457	–	–	0.02%	129
2013 Q4	$95K	Hold	1,457	–	–	0.02%	127
2013 Q3	$70K	Buy	+1,457	New	+$53.1K	0.01%	131

Other funds holding PCRX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Alerus Investment Advisors's PCRX Position: Q1 2016 in Review

Alerus Investment Advisors sold out of Pacira BioSciences (PCRX) in Q1 2016, closing a stake of 292 shares — an estimated $22K sold.

Alerus Investment Advisors first reported a position in PCRX in Q3 2013 and held it in 10 quarters. The position peaked at $134K in Q2 2014. 180 funds tracked by Wall St. Rank hold PCRX as of Q1 2016.

Alerus Investment Advisors reported no remaining Pacira BioSciences position as of Q1 2016 after selling out during the quarter.
Alerus Investment Advisors sold 292 Pacira BioSciences shares in Q1 2016, an estimated $22K.
Alerus Investment Advisors first reported a position in Pacira BioSciences in Q3 2013 and held it in 10 quarters.
Alerus Investment Advisors's Pacira BioSciences position peaked at $134K in Q2 2014.
180 funds tracked by Wall St. Rank held Pacira BioSciences as of Q1 2016.

Based on Alerus Investment Advisors's 13F filing for Q1 2016, filed 4 May 2016.